Presentation Duration of DAPT and Long-term Clinical Outcome After Coronary DES Implantation Presenter: T. Tada June 01, 2012
News Daily News CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events L.A. McKeown June 01, 2012
News Industry News Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy May 15, 2012
News Industry News OrbusNeich’s Combo Dual Therapy Stent™ Featured During Symposium at Angioplasty Summit TCTAP 2012 April 25, 2012
News Daily News Se Publica el PRODIGY: No se observa Ventaja alguna a Largo Plazo con el Clopidogrel April 03, 2012
Presentation Short- vs. Long-term Duration of Dual Antiplatelet Therapy (DAPT) After Coronary Stenting Presenter: Marco Valgimigli April 02, 2012
News Daily News Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES Caitlin E. Cox March 25, 2012
News Industry News REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES November 13, 2011
News Industry News Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events November 08, 2011
News Conference News Mock Jury Votes on DAPT Duration: 12 Months Remains Best Option for Most Patients November 08, 2011
News Industry News Three-Year Clinical Outcomes from Use of GenousTM Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy November 07, 2011
News Conference News ESC Congress 2011: Drugs, Devices Work Together Caitlin E. Cox September 06, 2011
News Conference News EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES Caitlin E. Cox April 05, 2011
CME Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes